Rate the Article: Clomiphene Citrate in Obesity - Associated Hypogonadism, IJSR, Call for Papers, Online Journal
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 9 | Views: 307 | Weekly Hits: ⮙3 | Monthly Hits: ⮙4

Review Papers | Medicine | Brazil | Volume 12 Issue 8, August 2023 | Rating: 5.3 / 10


Clomiphene Citrate in Obesity - Associated Hypogonadism

Mateus Andrade Misson, Carlos Oliveira Leal Neto, Lucas Querino Wirz, Daniel Martins Borges, Thalita Leal Leite Pimenta


Abstract: This study investigates the benefits of Clomiphene Citrate CC in treating obesity-associated secondary hypogonadism. An integrative review was conducted, focusing on pharmacodynamic principles, risk-benefit, safety, and therapeutic effectiveness. The study concludes that CC is a safe and effective therapy for hypogonadotropic hypogonadism, especially beneficial for those desiring fatherhood.


Keywords: Hypogonadism. Male Obesity, ClomiphenCitrat. Fertility, Hypothalamic-Pituitary-Gonadal Axis


Edition: Volume 12 Issue 8, August 2023,


Pages: 61 - 66



Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments (Only high quality comments will be accepted.)

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top